- AMINOIMIDAZOPYRIDINES AS KINASE INHIBITORS
-
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, (I) are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
- -
-
Page/Page column 91
(2019/05/22)
-
- IMIDAZO-FUSED HETEROCYCLES AND USES THEREOF
-
Compounds and methods in the fields of chemistry and medicine are disclosed. Some of the disclosed embodiments include compounds, compositions and methods of using imidazole-fused heterocycle amines. Some of the disclosed embodiments include imizazo-fused
- -
-
Paragraph 0140; 0141
(2016/10/31)
-
- MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE
-
The present invention relates to modulators of IRAK kinase and provides compositions comprising such modulators, as well as methods therewith for treating conditions or diseases mediated by or associated with IRAK kinase.
- -
-
Page/Page column 19
(2011/02/18)
-
- FUSED BICYCLIC COMPOUNDS AS INHIBITORS FOR PI3 KINASE
-
The invention relates to compounds of formula (I) for the regulation of phosphoinositides 3-kinases activity and related diseases.
- -
-
Page/Page column 163
(2010/09/18)
-
- FUSED BICYCLIC COMPOUNDS AND USE THEREOF AS PI3K INHIBITORS
-
The invention relates to compounds of formula (I), for the regulation of phosphoinositides 3-kinases activity and related diseases.
- -
-
Page/Page column 88
(2009/12/05)
-
- Inhibitors of PI3 kinase
-
The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.
- -
-
Page/Page column 20
(2009/07/10)
-